---
$id: https://graph.org.ai/products/commodity/51171937
$type: Product
source: UNSPSC
code: "51171937"
title: "Ebrotidine"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ebrotidine

**UNSPSC Code**: 51171937
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-2 receptor antagonist with the molecular formula C14H17BrN6O2S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TMZ3IBW2OW, chemically known as benzenesulfonamide, n-(((2-(((2-((aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)ethyl)amino)methylene)-4-bromo-, (e)- but generally known as ebrotidine, which bears US NIH Compound Identifier 65869. European Medicines Agency schedules Ebrotidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06438MIG. The term EBROTIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). Most nations schedule ebrotidine under HS 29350090 and SITC 51580. As of Q4 2014, EBROTIDINE remains the US FDA Preferred Term for this commodity. Ebrotidine bears US NLM identifiers UMLS ID C0169307 and NCI Concept Code C77440. SMILES: BRC1CCC(S(=O)(=O)N/C=N/CCSCC2NC(SC2)/N=C(/N)N)CC1.

